Top Markets
#1 ORDI ORDI +105.28%
#2 pippin pippin +48.89%
#3 tomiNet tomiNet +42.76%
#4 SATS (Ordinals) SATS (Ordinals) +41.44%
#5 1000SATS (Ordinals) 1000SATS (Ordinals) +40.63%
#6 Axelar Axelar +28.30%
#7 Bio Protocol Bio Protocol +27.90%
#8 Swarms Swarms +26.30%
#9 Drift Protocol Drift Protocol +25.62%
#10 MemeCore MemeCore +24.82%
Coin of the day
ORDI ORDI
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Neovacs S.A. Neovacs S.A.

Neovacs S.A.

ALNEV
Peringkat dalam Saham #21228
Neovacs S.A., a biotechnology company, focuses on the development of... Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for chronic autoimmune and inflammatory diseases using its proprietary Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of systemic lupus erythematosus; Phase IIa clinical trial for the treatment of dermatomyositis; and preclinical stage for the treatment of diabetes. It is also developing VEGF-Kinoid, which is in preclinical stage for the treatment of age-related macular degeneration and solid tumors; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company has a collaboration with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal and ovarian cancer. Neovacs S.A. was founded in 1993 and is based in Paris, France.
Harga Saham
$0.00047446
Kapitalisasi Pasar
$82.80
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-98.16%
Negara
FR
Perdagangan Neovacs S.A. (ALNEV)

Kategori

Healthcare
Margin Operasi untuk Neovacs S.A. (ALNEV)
Margin Operasi per April 2026 TTM: -1,846.44%
Menurut laporan keuangan dan harga saham terbaru dari Neovacs S.A., margin operasi saat ini (TTM) adalah -1,846.44%. Pada akhir 2023, margin operasi perusahaan adalah -1,294.97%.
Riwayat margin operasi untuk Neovacs S.A. dari 2007 hingga 2026
Margin Operasi pada akhir setiap tahun
Tahun Margin Operasi Mengubah
2026 (TTM) -1,846.44% 0.00%
2024 -1,846.44% 42.59%
2023 -1,294.97% -99.78%
2022 -579,583.27% 1,570.47%
2021 -34,695.90% 195.85%
2020 -11,727.38% 0.00%
2019 0.00% -100.00%
2018 -9,020.69% 0.00%
2017 0.00% -100.00%
2016 -111,411.14% 1,245.37%
2015 -8,281.07% 22.13%
2014 -6,780.72% -74.35%
2013 -26,437.94% 0.00%
2012 0.00% 0.00%
2011 0.00% 0.00%
2010 0.00% 0.00%
2009 0.00% -100.00%
2008 -12,827.49% 212.34%
2007 -4,106.85% 0.00%
Margin Operasi untuk perusahaan sejenis atau pesaing
Perusahaan Margin Operasi Perbedaan Margin Operasi Negara
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
41.30% -100.02%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
35.45% -100.02%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
24.95% -100.01%
US
UCB SA UCB SA
UCB SA
UCB.BR
25.32% -100.01%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
25.64% -100.01%
NL
Apa itu Margin Operasi perusahaan?
Margin Operasi adalah indikator utama untuk menilai profitabilitas suatu perusahaan. Margin Operasi yang lebih tinggi umumnya lebih baik karena menunjukkan bahwa perusahaan mampu menjual produk atau layanan mereka dengan harga yang jauh lebih tinggi daripada biaya produksinya. Margin Operasi dihitung dengan membagi laba perusahaan dengan pendapatannya.